Reporting on Methods in Clinical Trials
Authors:
- Rebecca DerSimonianRDRebecca DerSimonian
- L.Joseph CharetteLCL.Joseph Charette
- Bucknam McPeekBMBucknam McPeek
- Frederick MostellerFMFrederick Mosteller
- 3 June 1982
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 306 (22) , 1332-1337
Abstract
A clinical trial cannot be adequately interpreted without information about the methods used in the design of the study and the analysis of the results. To determine the frequency of reporting what we consider 11 important aspects of design and analysis, we surveyed all 67 clinical trials published in the New England Journal of Medicine, the Lancet, and the British Medical Journal from July through December 1979 and in the Journal of the American Medical Association from July 1979 through June 1980. Of all 11 items in the 67 trials published in all four journals, 56 per cent were clearly reported, 10 per cent were ambiguously mentioned, and 34 per cent were not reported at all.Keywords
This publication has 6 references indexed in Scilit:
- Reporting standards and research strategies for controlled trialsControlled Clinical Trials, 1980
- Problems of omission in communicationsClinical Pharmacology & Therapeutics, 1979
- Should There Be Statistical Guidelines for Medical Research Papers?1978
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Guidelines for reporting clinical trialsJournal of Periodontal Research, 1974
- THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLESBiometrika, 1950